ALLERGAN
Manufacturer adverse-event records for ALLERGAN come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 1995–2026 · mid-book · elevated Death-code · injury-heavy
Injury-mix signature
ALLERGAN leans injury-heavy in event_type mix
Injury-coded event_type share is 64.4% (injury-heavy tercile) beside 1.01% Death-coded (elevated). Volume band: mid.
What the Injury-mix reading shows for ALLERGAN
The standout signal for ALLERGAN is Injury-mix: 64.4% Injury-coded (injury-heavy) beside 1.01% Death-coded, on a mid-book footprint.
Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for ALLERGAN. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.
Reports span 20 device types, led in this extract by Injury at 5,819 (64.4% of event_type total). Peak single-year volume reaches 1,362 reports across 31 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (20)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.